Cellectar Biosciences, Inc. · NASDAQ:CLRB
Bleichroeder LP reported a 9.99% stake in Cellectar Biosciences, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 13, 2026
Bleichroeder LP reported a 9.99% stake in Cellectar Biosciences, Inc., 808,300 shares, as a passive investor on Jun 30, 2026. Filed Aug 13, 2026 (Schedule 13G).
- Stake
- 9.99%
- Shares
- 808,300
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Bleichroeder LP | 9.99% | 808,300 |
| Bleichroeder Holdings LLC | 9.99% | 808,300 |
| Andrew Gundlach | 9.99% | 808,300 |
Source
Related
- Cellectar Biosciences, Inc.
- Bleichroeder LP
- Cellectar Biosciences, Inc. shareholders
- Schedule 13G/A · Bleichroeder LP · Feb 13, 2026
- Schedule 13G · Bleichroeder LP · Nov 14, 2025
- Schedule 13G · Stempoint Capital LP · Aug 14, 2026
- Schedule 13G · Silverarc Capital Management, LLC · Aug 14, 2026
- Schedule 13G · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G · Caligan Partners LP · Aug 14, 2026
- Schedule 13G · Empery Asset Management, LP · Aug 4, 2026